In The News

10.16.18

CMS Proposes Requirement for Television Ads to Disclose Drug Prices

Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with Inside Health Policy for an article on the Centers for Medicare & Medicaid Services’ proposal.


10.08.18

California Fights Back Against Pharmaceutical Industry

Manatt’s Ian Spatz, a senior advisor with our Manatt Health team, was quoted by the Los Angeles Times in an article on California’s call for drug pricing transparency.


07.22.18

Drug Companies Might Feel Pressured to Lower Prices

Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with The Hill for an article on drug companies and where they stand on raising or lowering their prices.


05.19.18

Plan to Lower Drug Pricing Could Be Underwhelming

Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with The Hill for an article on President Trump’s chief health official and the administration’s plans to lower prescription drug prices.  


05.15.18

Trump’s Plan to Lower Drug Spending Includes Merging Medicare Drugs

Manatt’s Ian Spatz, a senior advisor with Manatt Health, was quoted by ThinkProgress for an article on President Trump’s alternative to Medicare drug negotiations.


05.15.18

Medicare Prescription Drug Spending for 2016 Totals $174B

Manatt’s Ian Spatz, a senior advisor with Manatt Health, was quoted by CNN News for an article on the Centers for Medicare & Medicaid Services’ spending on prescription medications.


05.07.18

Lobbyists, Experts Discuss President’s Upcoming Drug Pricing Speech

Manatt’s Ian Spatz, an advisor with Manatt Health, was interviewed by Stat News for an article on President Trump’s upcoming speech on drug pricing.


04.19.18

Trump’s Plans to Lower Drug Costs Remain Mystery to Congress

Manatt’s Ian Spatz, a senior advisor with Manatt Health, was quoted by Inside Health Policy for an article examining the administration’s plan to lower the cost of prescription drugs.According to the publication, Congress has not been privy to the specifics of President Trump’s ...


02.06.17

Candidates for FDA Commissioner Narrow to Two

Politico quoted Manatt’s Ian Spatz, a senior advisor with Manatt Health, in an article about the anticipation building ahead of an FDA commissioner appointment.The publication reports that most onlookers believe the choice for the appointment is down to two candidates—Scott Gottlieb and ...


11.16.16

ACOs Unlikely to Be Threatened in ACA Repeal

Inside Health Reform quoted Manatt’s Ian Spatz, a senior advisor with Manatt Health, in an article about the likelihood that Republicans will retain accountable care organizations (ACOs) despite repealing the Affordable Care Act.Spatz said the origins of ACOs predate the ACA, and he said ...